SUPERNUS PHARMACEUTICALS, INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Supernus Pharmaceuticals, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2022.
  • Supernus Pharmaceuticals, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $1.57M, a 98% decline year-over-year.
  • Supernus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$10.5M, a 92% increase from 2021.
  • Supernus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$130M, a 3765% decline from 2020.
  • Supernus Pharmaceuticals, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2020 was $3.56M, a 9.39% decline from 2019.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$10.5M +$120M +92% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-09
2021 -$130M -$134M -3765% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-09
2020 $3.56M -$369K -9.39% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-09
2019 $3.93M -$373M -99% Jan 1, 2019 Dec 31, 2019 10-K 2022-04-13
2018 $376M +$371M +6526% Jan 1, 2018 Dec 31, 2018 10-K 2021-03-08
2017 $5.68M +$3.63M +177% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-28
2016 $2.05M +$185K +9.91% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-01
2015 $1.87M -$28.7M -93.9% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-01
2014 $30.6M -$32.2M -51.3% Jan 1, 2014 Dec 31, 2014 10-K/A 2017-01-20
2013 $62.7M -$25.2M -28.6% Jan 1, 2013 Dec 31, 2013 10-K/A 2017-01-20
2012 $87.9M +$60.8M +225% Jan 1, 2012 Dec 31, 2012 10-K 2015-03-12
2011 $27.1M +$28M Jan 1, 2011 Dec 31, 2011 10-K 2014-03-21
2010 -$944K Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.